Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16309298 | 0.83 | THRB (0.50) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL4196703 | 0.83 | THRB (0.50) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL1326895 | 0.81 | THRB (0.48) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL9806275 | 0.81 | THRB (0.48) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL20614659 | 0.81 | THRB (0.42) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL2807372 | 0.80 | ALDH1A1 (0.56) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL11969909 | 0.80 | ALDH1A1 (0.56) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL7257389 | 0.80 | THRB (0.47) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL4977814 | 0.80 | THRB (0.47) | THRBTSHRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL28357528 | 0.80 | THRB (0.41) | THRBTSHRALDH1A1CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024043222-A1 | PHOTOSENSITIVE SURFACE TREATMENT AGENT, LAMINATE, SUBSTRATE FOR PATTERN FORMATION, TRANSISTOR, PATTERN FORMATION METHOD, AND TRANSISTOR MANUFACTURING METHOD | 株式会社ニコン | 2024-02-29 | — | — | WO | disclosed |
| WO-2018128678-A2 | COMPOSITIONS AND METHODS FOR RESTRUCTURING CHEMICALLY TREATED HAIR | L'OREAL (FR) | 2018-07-12 | — | — | WO | disclosed |
| WO-2018093575-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE QUALITY OF CHEMICALLY TREATED HAIR | L'OREAL (FR) | 2018-05-24 | — | — | WO | disclosed |
| WO-2012021472-A2 | COMPOSITIONS AND METHODS FOR SEALING THE SURFACE OF KERATINOUS SUBSTRATES | L'OREAL S. A. (FR) | 2012-02-16 | — | — | WO | disclosed |
| EP-1855643-A1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | L'OREAL (FR) | 2007-11-21 | — | — | EP | disclosed |
| EP-1855638-A1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT ANTHRAQUINONE DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | L'Oréal (FR) | 2007-11-21 | — | — | EP | disclosed |
| US-20060230546-A1 | Anhydrous composition in the form of a film comprising at least one film-forming polymer and at least one oxidation dye, preparation, and dyeing process | L'OREAL S.A. (FR) | 2006-10-19 | — | — | US | disclosed |
| WO-2006089809-A1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT ANTHRAQUINONE DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | L'OREAL (FR) | 2006-08-31 | — | — | WO | disclosed |
| WO-2006089806-A1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | L'ORÉAL (FR) | 2006-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060230546-A1 | Anhydrous composition in the form of a film comprising at least one film-forming polymer and at least one oxidation dye, preparation, and dyeing process | KRT18, DSG1, DSP | THRB 4153/4885TSHR 4877/4885ALDH1A1 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.